Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
Seagen Inc.
Corvus Pharmaceuticals, Inc.
Hoffmann-La Roche
Bristol-Myers Squibb
SymBio Pharmaceuticals
Seagen Inc.